| |
| Maximus release aims to reduce osteoporosis rate |
| |
Our country’s economic factorothers of the region are now critical in the fight against osteoporosis.Nowadays, this situation could be reversed due to the release of Maximus, by the Peruvian pharmaceutical company, Hersil. This product is designed to cover a comprehensiveeconomic treatment in the fight against the dreaded osteoporosis.
It is proven that the combination of alendronic acidcalcium citrate are important molecules in the treatment of osteoporosis,if we add a low cost which would be below most similar molecules available for treatment, we have an interesting new option to treat the disease that will attack, according to Peruvian studies one of every 3 women in postmenopausal age said Carlos Izaguirre, Hersil’s laboratory manager.
Unfortunately patients do not care about prevention of this disease, because there are no symptoms associated with great loss of bone quality, regrettably; we only find out when we have a fracture, the most serious complication, says Dr. David Rivers, traumatology specialist.
There are many products on the market for the treatment of this non-transmissible disease, which do not guarantee a comprehensive treatment for the patients who demand results from their investment. It is also known that calcium citrate ingestion produces less gastrointestinal discomfort, less risk of suffering from kidney stones, unlike calcium carbonate.
Nowadays, one of four fractures evidenced, occur in Latin Americawith the increased population longevity, this number may increase to one of two in the next 50 years, according to the International Osteoporosis Foundation.
The Osteoporosis is a disease in which bones become more porousfragile, increasing the numberextent of cavitiescells inside them. Thus, the bones become thinnermore fragile,do not resist well blows, breaking easily.
Hersil Laboratories, once again fulfills its mission of working for the health of Peruvians.  |
| |
|
